equityflowunderstand the flow and follow it

Oviva

Healthtech · CH · oviva.com

Reimbursed digital therapeutics for obesity and chronic diseases, integrated into the healthcare systems of Germany, the UK and Switzerland.

Founders

Kai Eberhardt (Germany · ♂) — Recognizing that half of Europe is overweight yet lacks personalized long-term treatment, he co-founded Oviva in 2014 as CEO to combine dietitian coaching with a smart app working directly with health insurers.
Manuel Baumann (Switzerland · ♂) — A co-founder and CTO who built Oviva's app-based platform for digital dietary and lifestyle coaching.
Mark Jenkins (United Kingdom · ♂) — A medical doctor who co-founded Oviva and leads its UK operations as managing partner and medical director, bringing clinical credibility to its diabetes-focused care.

Shares the most investors with (number = shared investors):

Date	Round	Amount
Jan 2026	Series D Plus Oviva raised a 200 million euro Series D (new equity and secondary) from Kinnevik, Planet First Partners, A.P. Moller Holding and others to bring digital obesity care to more European health systems.	$232M
Sep 2021	Series C Potsdam/Swiss e-health company Oviva (digital type-2 diabetes therapy) raised USD80M from Sofina, Temasek and existing investors.	$80M

Tap an investor to see what else they have backed.

Data is community-curated and may be incomplete.